We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.9B
AUM Growth
+$137M
Cap. Flow
+$88.8M
Cap. Flow %
3.06%
Top 10 Hldgs %
17.97%
Holding
1,008
New
71
Increased
442
Reduced
400
Closed
82

Top Buys

Rank Stock Value
1
VGM icon
Invesco Trust Investment Grade Municipals
VGM
+$4.8M
2
NMZ icon
Nuveen Municipal High Income Opportunity Fund
NMZ
+$4.39M
3
MQY icon
BlackRock MuniYield Quality Fund
MQY
+$4.26M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.84M
5
OLMA icon
Olema Pharmaceuticals
OLMA
+$3.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$19.8M
2
ETNB
89bio
ETNB
+$3.65M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$3.59M
4
RKLB icon
Rocket Lab Corp
RKLB
+$3.39M
5
VMO icon
Invesco Municipal Opportunity Trust
VMO
+$3.16M

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 11.66%
3 Financials 9.01%
4 Industrials 7.22%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRTC icon
426
iRhythm Holdings
IRTC
$4.02B
$1.44M 0.05%
8,120
+1,078
+15% +$191K
XBI icon
427
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$1.44M 0.05%
11,809
-116
-1% -$13.3K
XLF icon
428
State Street Financial Select Sector SPDR ETF
XLF
$59B
$1.44M 0.05%
26,249
-232
-0.9% -$12.4K
MC icon
429
Moelis & Co
MC
$4.93B
$1.44M 0.05%
20,902
-2,414
-10% -$161K
RVT icon
430
Royce Value Trust
RVT
$2.3B
$1.43M 0.05%
89,077
-23,423
-21% -$375K
RARE icon
431
Ultragenyx Pharmaceutical
RARE
$2.66B
$1.43M 0.05%
62,173
-11,621
-16% -$382K
ETR icon
432
Entergy
ETR
$49.7B
$1.43M 0.05%
15,425
+5,705
+59% +$541K
TXN icon
433
Texas Instruments
TXN
$257B
$1.42M 0.05%
8,176
-3,820
-32% -$654K
ORIC icon
434
Oric Pharmaceuticals
ORIC
$1.42B
$1.39M 0.05%
170,072
+23,024
+16% +$265K
JBL icon
435
Jabil
JBL
$37.4B
$1.39M 0.05%
6,092
-92
-1% -$19.6K
FLEX icon
436
Flex
FLEX
$45.2B
$1.39M 0.05%
22,949
+3,175
+16% +$196K
GGG icon
437
Graco
GGG
$13.5B
$1.38M 0.05%
16,879
+1,240
+8% +$102K
CMF icon
438
iShares California Muni Bond ETF
CMF
$4.62B
$1.38M 0.05%
24,004
+7,564
+46% +$434K
LEN icon
439
Lennar Class A
LEN
$21.1B
$1.38M 0.05%
13,382
-705
-5% -$85.1K
PSX icon
440
Phillips 66
PSX
$89.5B
$1.37M 0.05%
10,639
-2,589
-20% -$348K
DHR icon
441
Danaher
DHR
$146B
$1.37M 0.05%
5,968
-32
-0.5% -$7.03K
REYN icon
442
Reynolds Consumer Products
REYN
$5.51B
$1.37M 0.05%
59,589
-7,389
-11% -$178K
OCGN icon
443
Ocugen
OCGN
$465M
$1.36M 0.05%
+1,005,981
New +$1.43M
STT icon
444
State Street
STT
$51.4B
$1.36M 0.05%
+10,505
New +$1.26M
RGNX icon
445
Regenxbio
RGNX
$703M
$1.35M 0.05%
93,917
-47,809
-34% -$596K
DRI icon
446
Darden Restaurants
DRI
$25B
$1.35M 0.05%
7,349
+1,095
+18% +$200K
BSCT icon
447
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.93B
$1.35M 0.05%
71,762
+23,753
+49% +$448K
NJR icon
448
New Jersey Resources
NJR
$5.55B
$1.35M 0.05%
29,222
-3,326
-10% -$154K
VSTM icon
449
Verastem
VSTM
$638M
$1.35M 0.05%
+174,384
New +$1.55M
TROW icon
450
T. Rowe Price
TROW
$24.3B
$1.34M 0.05%
13,088
-1,335
-9% -$138K
16 17
18
19 20

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Hennion & Walsh Asset Management held 1,008 positions worth $2.9B, up 5% from $2.76B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management deployed $88.8M of net new capital in Q4 2025, opening 71 new positions and adding to 442 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Rhythm Pharmaceuticals, an estimated $3.59M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2025 buy was Schwab Fundamental International Large Company Index ETF: 53,014 shares worth $2.4M.
  • Hennion & Walsh Asset Management added most to Invesco Trust Investment Grade Municipals in Q4 2025, an estimated $4.8M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2025 reduction was Rhythm Pharmaceuticals, cutting an estimated $3.59M.
  • Hennion & Walsh Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $19.8M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $2.9B portfolio in Q4 2025.
  • Hennion & Walsh Asset Management opened 71 new positions and closed 82 in Q4 2025.
  • Hennion & Walsh Asset Management's portfolio value rose 5% quarter-over-quarter to $2.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2025, filed 14 Jan 2026.